Rigel receives orphan drug designation by the FDA for its myelodysplastic syndrome treatment Rigel receives orphan drug designation by the FDA for its myelodysplastic syndrome treatment Post ContentriglRead More You might also be interested in reading PR advice that crypto founders wish they’d heard sooner. January 9, 2025 In Mainstream ← Previous post Next post →